BroadOak Capital Partners

Sobre

Life-sciences growth-capital specialist investing flexible permanent capital in commercial-stage tools, diagnostics, biopharma services and related healthcare-infrastructure companies from initial revenue through profitability.

Sectores

• Ciencias de la vida

Inversiones destacadas

• Insphero
• Axol Bioscience
• EpiCypher
• Harvard Bioscience
• Cayman Chemical
• Active Motif
• Solvias
• Quartzy

Inversores

• Austin DukeManaging Director→
• Bill SniderPartner→
• Calvin AubreyVice President→
• Daniel FriedmanManaging Director→
• Henry DervishiAssociate→
• Lars HananPartner→
• Matt McFarlandPartner→
• Max WeisSenior Associate→
• Michael CaspaniManaging Director→
• Tim JohnsonPartner→

Cómo contactarlos

https://broadoak.com/contact/